Marko Skelin

Sibenik, 22000, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 64 publications

Chronotherapy in Oncology: Aligning Cancer Treatment with Biological Time.

Chronotherapy in Oncology: Aligning Cancer Treatment with Biological Time.

Journal: Journal of personalized medicine

Published: June 08, 2026

Increase in mean corpuscular volume during treatment with hydroxyurea in patients with essential thrombocythemia and polycythemia vera does not predict clinical outcomes.

Increase in mean corpuscular volume during treatment with hydroxyurea in patients with essential thrombocythemia and polycythemia vera does not predict clinical outcomes.

Journal: Scandinavian journal of clinical and laboratory investigation

Published: January 29, 2026

Association of Cancer-Associated Venous Thromboembolism with the Primary Site of Colorectal Cancer, with Respect to KRAS/NRAS/BRAF Mutations.

Association of Cancer-Associated Venous Thromboembolism with the Primary Site of Colorectal Cancer, with Respect to KRAS/NRAS/BRAF Mutations.

Journal: Biomedicines

Published: December 24, 2025

Correspondence on "Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements" by Barzel et al.

Correspondence on "Stability of alglucosidase alfa in 0.9% sodium chloride for enzyme replacement therapy in patients with Pompe disease: insights from enzyme activity and cellular uptake measurements" by Barzel et al.

Journal: European journal of hospital pharmacy : science and practice

Published: December 23, 2025

Factors associated with intentional non-adherence to endocrine treatment among early breast cancer survivors: A multicenter cross-sectional study.

Factors associated with intentional non-adherence to endocrine treatment among early breast cancer survivors: A multicenter cross-sectional study.

Journal: British journal of clinical pharmacology

Published: December 23, 2025

Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence.

Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence.

Journal: Pharmacology research & perspectives

Published: October 30, 2025

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Prevalence of Chronic Obstructive Pulmonary Disease and Asthma in Polycythemia Vera and Essential Thrombocythemia and Its Prognostic Implications.

Journal: Journal of clinical medicine

Published: October 26, 2025

Development of Digital Literacy: Application of Artificial Intelligence in Education and Clinical Practice of Oncology Nurses.

Development of Digital Literacy: Application of Artificial Intelligence in Education and Clinical Practice of Oncology Nurses.

Journal: Seminars in oncology nursing

Published: August 27, 2025

Differentiating polycythemia vera from sodium-glucose cotransporter 2 inhibitor-associated polycythemia.

Differentiating polycythemia vera from sodium-glucose cotransporter 2 inhibitor-associated polycythemia.

Journal: Acta diabetologica

Published: August 14, 2025

Immunotherapy in mesothelioma - systematic review and meta-analysis of immunotherapy impact on OS and its correlation with PFS and ORR.

Immunotherapy in mesothelioma - systematic review and meta-analysis of immunotherapy impact on OS and its correlation with PFS and ORR.

Journal: Journal of chemotherapy (Florence, Italy)

Published: April 23, 2025

Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty-Clinical Implications and Budget Impact.

Aspirin Versus LMWH for Thromboprophylaxis Following Hip or Knee Arthroplasty-Clinical Implications and Budget Impact.

Journal: Pharmacology research & perspectives

Published: February 21, 2025

High lymphocyte count and bleeding risk in patients with chronic lymphocytic leukemia treated with Bruton's tyrosine kinase inhibitors.

High lymphocyte count and bleeding risk in patients with chronic lymphocytic leukemia treated with Bruton's tyrosine kinase inhibitors.

Journal: Wiener klinische Wochenschrift

Published: February 02, 2025

Showing 1-12 of 64

Last Updated: 09/26/2026